BAWEI
837023
XI'AN WONDER
836419
Jiangsu Tiangong Technology
920068
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
CN Stock MarketDetailed Quotes
688293 Shanghai OPM Biosciences
- 41.10
- +0.59+1.46%
Market Closed May 15 15:00 CST
4.67BMarket Cap289.44P/E (TTM)
41.81High40.41Low4.69KlotVolume40.51Open40.51Pre Close19.26MTurnover0.61%Turnover Ratio222.16P/E (Static)113.55MShares48.6752wk High2.21P/B3.18BFloat Cap24.5052wk Low48.61Limit Up77.41MShs Float97.48Historical High32.41Limit Down3.46%Amplitude24.50Historical Low0.45Dividend TTM41.08Avg Price1.94KlotAsk1.10%Div YieldTTM100Lot Size2.49KlotBid
Shanghai OPM Biosciences Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -35.10%737.06M | -30.50%891.14M | -26.71%940.15M | -22.30%952.56M | -19.82%1.14B | -14.85%1.28B | -27.56%1.28B | 330.42%1.23B | --1.42B | 385.24%1.51B |
| Transactional financial assets | 86.16%449.69M | 140.73%358.08M | 95.65%333.3M | 35.44%313.14M | 41.59%241.56M | -12.86%148.75M | --170.35M | --231.21M | --170.61M | --170.71M |
| Notes receivable and accounts receivable | -16.71%105.5M | 15.05%110.85M | 10.15%90.9M | 23.13%111.39M | 58.34%126.66M | 25.44%96.35M | 51.63%82.53M | -3.26%90.46M | --80M | 83.99%76.81M |
| -Notes receivable | 153.10%9.24M | 116.30%8.92M | 29.55%7.58M | 119.16%5.98M | 71.13%3.65M | 337.60%4.12M | 1,717.00%5.85M | --2.73M | --2.13M | --942.43K |
| -Accounts receivable | -21.75%96.26M | 10.53%101.93M | 8.67%83.32M | 20.14%105.41M | 57.99%123.01M | 21.56%92.22M | 41.72%76.68M | -6.18%87.73M | --77.86M | 81.73%75.87M |
| Other receivables (including interest and dividends) | -50.44%4.17M | 3.79%8.57M | -3.56%8.76M | 7.56%8.44M | 7.17%8.42M | 2.65%8.26M | 8.54%9.08M | -3.31%7.85M | --7.85M | 184.18%8.04M |
| -Accrued interest receivable | --340.82K | --242.19K | --141.37K | --40.55K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other receivable | ---- | 0.85%8.33M | ---- | 7.04%8.4M | ---- | 2.65%8.26M | ---- | -3.31%7.85M | ---- | 184.18%8.04M |
| Advance payment | -81.57%315.15K | -76.19%373.99K | -88.18%466.71K | -68.72%931.28K | -13.20%1.71M | -23.24%1.57M | -13.96%3.95M | 34.35%2.98M | --1.97M | 38.57%2.05M |
| Inventories | 21.80%65.42M | 20.13%59.12M | 29.28%62.08M | 13.20%56.88M | 12.43%53.71M | 11.81%49.21M | 3.49%48.02M | 7.41%50.24M | --47.77M | 30.52%44.01M |
| Non-current assets due within one year | 303.37%214.1M | 63.65%86.14M | 76.45%107.51M | 33.32%53.52M | 32.45%53.08M | 31.35%52.64M | 21.65%60.93M | 0.15%40.14M | --40.07M | -0.25%40.07M |
| Other current assets | 60.37%33.11M | 71.02%34.8M | 47.50%32.26M | 137.44%31.68M | 13.08%20.65M | -3.81%20.35M | 59.28%21.87M | 9.82%13.34M | --18.26M | 94.17%21.16M |
| Adjustment items of current assets | ---- | ---- | ---- | ---- | --0.01 | ---- | ---- | ---- | ---- | ---- |
| Total current assets | -1.95%1.61B | -6.65%1.55B | -6.20%1.58B | -8.04%1.53B | -7.93%1.64B | -11.20%1.66B | -13.80%1.68B | 240.83%1.66B | --1.78B | 323.58%1.87B |
| Non Current assets | ||||||||||
| Debt investment | --20M | --20M | --20M | --20M | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-current financial assets | 0.68%43.53M | 0.68%43.53M | -0.08%43.23M | -0.08%43.23M | 261.57%43.23M | 261.57%43.23M | 268.24%43.27M | 440.85%43.27M | --11.96M | 49.46%11.96M |
| Fixed assets | ---- | -2.06%160.5M | ---- | 59.41%173.51M | ---- | 40.00%163.87M | ---- | 31.22%108.85M | ---- | 35.58%117.05M |
| Constru in process | ---- | 116.82%169.33M | ---- | -16.86%97.59M | ---- | -24.53%78.1M | ---- | 1,448.60%117.38M | ---- | 7,818.77%103.47M |
| Intangible assets | -3.97%37.1M | -3.90%37.68M | -2.98%38.31M | -2.21%38.4M | -2.93%38.63M | -2.78%39.21M | -3.38%39.48M | -5.15%39.27M | --39.8M | -5.02%40.33M |
| Long deferred expense | 5.07%59.14M | -13.66%52.06M | 214.70%56.41M | 193.17%56.51M | 178.71%56.29M | 180.22%60.3M | -20.59%17.92M | -18.73%19.28M | --20.2M | -15.23%21.52M |
| Deferred tax assets | 72.68%3.58M | 72.68%3.58M | 123.81%3.17M | 132.09%3.17M | 119.22%2.08M | 147.18%2.08M | 145.80%1.42M | 145.56%1.37M | --946.7K | 570.28%839.59K |
| Usufruct assets | -14.49%44.98M | -15.21%46.59M | -11.08%50.98M | 36.31%53.52M | 27.09%52.6M | 26.27%54.95M | 17.30%57.33M | -24.63%39.26M | --41.39M | -21.14%43.52M |
| Other non current assets | -43.17%125.49M | -20.56%159.61M | -43.73%130.41M | -16.11%214.09M | -2.44%220.82M | 43.21%200.92M | 40.01%231.74M | 159.42%255.21M | --226.34M | 61.09%140.3M |
| Total non current assets | 5.50%698.32M | 14.71%737.17M | 8.95%682.97M | 18.94%742.02M | 16.28%661.93M | 34.17%642.66M | 60.45%626.86M | 98.26%623.87M | --569.25M | 56.59%478.99M |
| Adjustment items of total assets | ---- | ---- | ---- | --0.01 | ---- | ---- | ---- | ---- | ---- | ---- |
| Total assets | 0.19%2.31B | -0.69%2.29B | -2.08%2.26B | -0.68%2.27B | -2.07%2.3B | -1.95%2.3B | -1.40%2.31B | 184.92%2.29B | 207.44%2.35B | 214.26%2.35B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -85.72%5M | --20.02M | -50.01%20.02M |
| Notes payable and accounts payable | 63.29%67.06M | 67.63%62.8M | 64.23%42.76M | 48.20%39.75M | 71.67%41.07M | 75.77%37.46M | 23.28%26.04M | 31.72%26.82M | --23.92M | 55.02%21.31M |
| -Accounts payable | 63.29%67.06M | 67.63%62.8M | 64.23%42.76M | 48.20%39.75M | 71.67%41.07M | 75.77%37.46M | 23.28%26.04M | 34.11%26.82M | --23.92M | 59.57%21.31M |
| Contract liabilities | 57.54%12.43M | 264.11%15.57M | 149.90%9.94M | 24.60%5.03M | 57.23%7.89M | -73.34%4.28M | -76.74%3.98M | -83.21%4.03M | --5.02M | -3.51%16.04M |
| Salaries payable | -21.05%6.35M | 19.73%13.58M | 57.51%9.71M | 60.64%8.11M | 66.60%8.04M | -13.72%11.34M | -29.98%6.16M | -23.62%5.05M | --4.83M | 43.22%13.15M |
| Taxs payable | 137.43%11.42M | 178.83%6.37M | 400.75%6.81M | 0.67%2.14M | 73.45%4.81M | 16.28%2.29M | -74.84%1.36M | -56.99%2.12M | --2.77M | -63.36%1.97M |
| Other payable (including interest and dividends) | 20.89%7.37M | 11.20%7.28M | -75.81%6.96M | 17.02%5.02M | 51.70%6.09M | 10.07%6.55M | 310.30%28.76M | 12.45%4.29M | --4.02M | 92.01%5.95M |
| -Dividend payable | ---- | ---- | ---- | ---- | ---- | ---- | --24.1M | ---- | ---- | ---- |
| -Other payable | ---- | 11.20%7.28M | ---- | 17.02%5.02M | ---- | 10.07%6.55M | ---- | 12.45%4.29M | ---- | 92.01%5.95M |
| Non current liabilities due within one year | 14.54%13.27M | 51.37%13.02M | 39.85%11.46M | 155.61%13.02M | 17.03%11.59M | -20.09%8.6M | -21.41%8.2M | -56.16%5.09M | --9.9M | 45.51%10.76M |
| Other current liabilities | 124.83%522.39K | 539.52%788.13K | 841.44%1.28M | 150.21%217.45K | 96.84%232.35K | 119.08%123.24K | 4.02%135.9K | -91.82%86.91K | --118.04K | -84.51%56.25K |
| Adjustment items of current assets | ---- | ---- | ---- | ---- | --0.01 | ---- | ---- | ---- | ---- | ---- |
| Total current liabilities | 48.54%118.42M | 69.04%119.42M | 19.14%88.91M | 39.58%73.28M | 12.93%79.73M | -20.85%70.65M | -25.39%74.63M | -51.15%52.5M | --70.6M | -6.85%89.26M |
| Current liabilities | ||||||||||
| Deferred tax liabilities | 125.14%1.33M | 125.14%1.33M | 55.03%1.55M | 78.92%1.55M | 110.06%592.31K | 127.55%592.31K | --1M | --868.94K | --281.97K | --260.3K |
| Long term deferred income | 120.29%26.41M | 46.95%17.89M | 8.19%11.67M | 6.21%11.84M | 1.90%11.99M | -2.89%12.18M | -12.81%10.79M | -14.81%11.15M | --11.76M | -13.69%12.54M |
| Lease liabilities | -13.67%50.47M | -13.93%52.32M | -11.45%55.9M | 25.13%58.32M | 19.17%58.46M | 21.21%60.79M | 21.27%63.14M | -12.83%46.61M | --49.06M | -11.24%50.15M |
| Total non current liabilities | 10.09%78.21M | -2.73%71.55M | -7.74%69.13M | 22.33%71.71M | -1.29%71.04M | -0.35%73.56M | -3.25%74.92M | -21.79%58.62M | --71.97M | -16.88%73.82M |
| Total liabilities | 30.42%196.63M | 32.43%190.97M | 5.68%158.04M | 30.48%144.99M | 5.75%150.76M | -11.57%144.21M | -15.73%149.55M | -39.09%111.12M | --142.56M | -11.67%163.07M |
| Shareholders equity | ||||||||||
| Paid-in capital | -1.07%113.55M | 0.00%114.77M | 0.00%114.77M | 0.00%114.77M | 40.00%114.77M | 40.00%114.77M | 40.00%114.77M | 86.67%114.77M | --81.98M | 33.33%81.98M |
| Capital reserve funds | -2.34%1.86B | 0.29%1.9B | -1.26%1.9B | -1.28%1.9B | -1.32%1.9B | -1.35%1.9B | 0.18%1.93B | 345.40%1.93B | --1.93B | 349.31%1.92B |
| Surplus reserve funds | 23.67%33.67M | 23.67%33.67M | 36.19%27.23M | 36.19%27.23M | 36.19%27.23M | 36.19%27.23M | 109.34%19.99M | 109.34%19.99M | --19.99M | 109.34%19.99M |
| Retained profit | -27.48%109.58M | -27.84%94.91M | 13.07%107.54M | 13.65%129.46M | -17.07%151.1M | -16.76%131.52M | -34.93%95.11M | -2.17%113.91M | --182.2M | 150.49%158.01M |
| Less:Treasury stock | ---- | 270.88%51M | --51M | --46.61M | --40M | --13.75M | ---- | ---- | ---- | ---- |
| Other composite income | 14.10%233.96K | 23.88%240.75K | -66.23%88.68K | -28.71%212.96K | 148.70%205.04K | 63.44%194.34K | 50.78%262.65K | --298.72K | --82.44K | --118.91K |
| Attributable parent company shareholders equity adjustment items | ---- | ---- | ---- | ---- | --0.01 | ---- | --0.01 | ---- | ---- | ---- |
| Shareholders equity without minority interests | -1.89%2.11B | -2.87%2.1B | -2.58%2.1B | -2.24%2.13B | -2.55%2.15B | -1.19%2.16B | -0.20%2.16B | 250.88%2.18B | 274.66%2.21B | 288.42%2.18B |
| Minority interests | -91.98%-1.58M | -88.37%-1.47M | -195.54%-1.25M | -267.88%-982.77K | -559.10%-825.01K | ---778.57K | ---422.85K | ---267.15K | ---125.17K | ---- |
| Total shareholder equity | -1.93%2.11B | -2.90%2.1B | -2.62%2.1B | -2.27%2.13B | -2.58%2.15B | -1.23%2.16B | -0.22%2.16B | 250.83%2.17B | 274.63%2.21B | 288.42%2.18B |
| Adjustment items of liabilities and equity | ---- | ---- | ---- | ---- | ---0.01 | ---- | ---- | ---- | ---- | ---- |
| Total liabilityies and equity | 0.19%2.31B | -0.69%2.29B | -2.08%2.26B | -0.68%2.27B | -2.07%2.3B | -1.95%2.3B | -1.40%2.31B | 184.92%2.29B | 207.44%2.35B | 214.26%2.35B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | -- |
| Auditor | -- | -- | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.